期刊文献+

KRT8对HBV复制影响的体外研究 被引量:1

An in Vitro Study of the Effect of KRT8 on the Replication of Hepatitis B Virus in HepG2.2.15 Cells
下载PDF
导出
摘要 目的:研究宿主蛋白KRT8对HBV复制的影响.方法:体外培养稳定表达HBV的肝癌细胞株(HepG2.2.15),分别用干扰KRT8基因的siRNA转染HepG2.2.15细胞和高表达KRT8基因的质粒转染HepG2.2.15细胞.RT-PCR验证转染效率,荧光定量PCR检测转染48小时后的细胞上清液HBV DNA水平.用拉米夫定抑制HepG2.2.15细胞HBV复制,RT-PCR检测基因表达水平.对数据采用t检验和方差分析,p<0.05为差异有统计学意义.结果:干扰KRT8基因表达后,HepG2.2.15细胞上清液中HBV DNA水平与对照组相比下降34%~38%(p<0.05).高表达KRT8基因后,HepG2.2.15细胞上清液中HBV DNA水平是对照组的28倍(p<0.01).抑制细胞HBV DNA复制后,HepG2.2.15细胞KRT8mRNA水平与对照组相比,下降了24%,但统计学无明显差异.结论:抑制宿主KRT8基因表达具有抗病毒作用. Objective. To investigate the effect of host protein KRT8 on HBV DNA replication. Methods. Hepatitis B virus (HBV)-transfected human hepatoblastoma cell line HepG2.2.15 was cultured in vitro. We used siRNA to silence KRT8 gene expression and plasmid vector to up regulate KRT8 gene expression and transfected them to HepG2.2.15 cells respectively. Forty-eight hours after the transfection, the cells were harvested for detecting the level of KRT8 gene expression and the culture supernatants were collected for measuring the level of HBV DNA replication. Lamivudine was selected to inhibit HBV DNA replica- tion and RT-PCR was chosen to detect the level of KRT8 gene expression. Statistical analysis was per- formed using the t test or ANOVA, when appropriate. A result of P〈0.05 was considered statistically significant. Results. When KRT8 mRNA was suppressed, the HBV DNA level in RNA interference groups was decreased by 34%-38% compared with that of the control group (P〈0.05). When KRT8 mRNA was over-expressed, the HBV DNA level was increased in vector group, 28 times that of the con- trol group (P〈0.01). When HBV DNA replication was inhibited, no significant difference was found be- tween the lamivudine group and the control group in their HBV DNA level (a decline of 24%). Conclu- sion. HBV DNA replication could be inhibited by suppressing KRT8 mRNA expression.
出处 《西南大学学报(自然科学版)》 CAS CSCD 北大核心 2012年第4期65-70,共6页 Journal of Southwest University(Natural Science Edition)
基金 国家自然科学基金资助项目(30972584,81171561)
关键词 KRT8 HBV复制 宿主蛋白 RNA干扰 KRT8 HBV replication host protein RNA interference
  • 相关文献

参考文献5

  • 1NGUYEN D H,GUMMULURU S,HU Jian-ming.Deamination-Independent Inhibition of Hepatitis B virus ReverseTranscription by APOBEC3G[J].J Virol,2007,81(9):4465-4472.
  • 2KU NAM-ON,STRNAD P,ZHONG Bi-hui,et al.Keratins Let Liver Live:Mutations Predispose to Liver Disease andCrosslinking Generates Mallory-Denk Bodies[J].Hepatology,2007,46(5):1639-1649.
  • 3TAO G Z,LOOI K S,TOIVOLA D M,et al.Keratins Modulate the Shape and Function of Hepatocyte Mitochondria:a Mechanism for Protection from Apoptosis[J].J Cell Sci,2009,122(Pt 21):3851-3855.
  • 4LI Lin,HU Jian-ming.Inhibition of Hepadnavirus Reverse Transcriptase-Epsilon RNA Interaction by Porphyrin Com-pounds[J].J Virol,2008.82(5):2305-2312.
  • 5Chun-Feng Lee,Zhi-Qiang Ling,Ting Zhao,Kuan-Rong Lee.Distinct expression patterns in hepatitis B virus-and hepatitis C virus-infected hepatocellular carcinoma[J].World Journal of Gastroenterology,2008,14(39):6072-6077. 被引量:3

二级参考文献18

  • 1[1]EI-Serag HB,Mason AC.Rising incidence of hepatocellular carcinoma in the United States.N Engl J Med 1999; 340:745-750
  • 2[2]Kasai Y,Takeda S,Takagi H.Pathogenesis of hepatocellular carcinoma:a review from the viewpoint of molecular analysis.Semin Surg Oncol 1996; 12:155-159
  • 3[3]Parkin DM,Pisani P,Ferlay J.Global cancer statistics.CA Cancer J Clin 1999; 49:33-64,1
  • 4[4]Okuda K,Fujimoto I,Hanai A,Urano Y.Changing incidence of hepatocellular carcinoma in Japan.Cancer Res 1987; 47:4967-4972
  • 5[5]Lee WM.Hepatitis B virus infection.N Engl J Med 1997; 337:1733-1745
  • 6[6]Perou CM,Jeffrey SS,van de Rijn M,Rees CA,Eisen MB,Ross DT,Pergamenschikov A,Williams CF,Zhu SX,Lee JC,Lashkari D,Shalon D,Brown PO,Botstein D.Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.Proc Natl Acad Sci USA 1999; 96:9212-9217
  • 7[7]Alizadeh AA,Eisen MB,Davis RE,Ma C,Lossos IS,Rosenwald A,Boldrick JC,Sabet H,Tran T,Yu X,Powell JI,Yang L,Marti GE,Moore T,Hudson J Jr,Lu L,Lewis DB,Tibshirani R,Sherlock G,Chan WC,Greiner TC,Weisenburger DD,Armitage JO,Warnke R,Levy R,Wilson W,Grever MR,Byrd JC,Botstein D,Brown PO,Staudt LM.Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.Nature 2000; 403:503-511
  • 8[8]Perou CM,Sorlie T,Eisen MB,van de Rijn M,Jeffrey SS,Rees CA,Pollack JR,Ross DT,Johnsen H,Akslen LA,Fluge O,Pergamenschikov A,Williams C,Zhu SX,Lonning PE,Borresen-Dale AL,Brown PO,Botstein D.Molecular portraits of human breast tumours.Nature 2000; 406:747-752
  • 9[9]Ross DT,Scherf U,Eisen MB,Perou CM,Rees C,Spellman P,Iyer V,Jeffrey SS,Van de Rijn M,Waltham M,Pergamenschikov A,Lee JC,Lashkari D,Shalon D,Myers TG,Weinstein JN,Botstein D,Brown PO.Systematic variation in gene expression patterns in human cancer cell lines.Nat Genet 2000; 24:227-235
  • 10[10]Welsh JB,Zarrinkar PP,Sapinoso LM,Kern SG,Behling CA,Monk BJ,Lockhart DJ,Burger RA,Hampton GM.Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.Proc Natl Acad Sci USA 2001; 98:1176-1181

共引文献2

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部